Table of Contents Table of Contents
Previous Page  270 / 330 Next Page
Information
Show Menu
Previous Page 270 / 330 Next Page
Page Background

270

28

TH

CONGRESS OF THE ESPU

12:51–12:54

S25-4 (PP)

A 5-YEAR PROSPECTIVE UROLOGICAL ASSESSMENT

OF IN UTERO MMC REPAIR: DOES GESTATIONAL AGE

AT BIRTH PLAY A ROLE AT LATER NEUROGENIC BLADDER

PATTERN?

Marcela LEAL DA CRUZ

1

, Antonio MACEDO JUNIOR

2

, Sergio LEITE

OTTONI

1

, Gilmar GARRONE

1

, Riberto LIGOURI

1

, Maria Isabel SILVA SILVA

1

and Jorge ANTONIO POMPERMAIER

1

1) CACAU - Centro de apoio a criança com anomalia urológica, NUPEP, Sao Paulo, BRAZIL - 2) Federal University

of Sao Paulo, Departament of pediatric, Sao Paulo, BRAZIL

PURPOSE

Amajor complication of in utero myelomeningocele (MMC) repair is premature delivery. The prema-

turity rate in Management of Myelomeningocele Study (MOMS) was 79%, with a mean gestational

age (GA) at birth of 34 weeks. Considering this particular aspect of prenatal surgery group, we

speculated if prematurity could also influence the urological outcome.

MATERIAL AND METHODS

Since November 2011, we prospectively follow a population of MMC patients that had undergonein

uterorepair. We compared the urological status of this population according to GA at birth: below

34weeks (group 1) and 34weeks or above (group 2). We reviewed clinical history, renal sonogram,

VCUG and urodynamics following a previously reported protocol.

RESULTS

We studied 79 patients,42 at group 1 and 37 at group 2. Mean GA at birth was 28.3 (25 -33) weeks

in group 1 and 35.2 (34-38) weeks in group 2. Patients were classified as high risk in 47.5% of group

1 and 54.5% of group 2, incontinent in 35% of group 1 and 33.3% of group 2, hypocontractile in

10% of group 1 and normal pattern in 7.5% of group 1 and 12.1% of group 2, none with statistical

significance. Mean follow up was 27,9 and 24,3months for groups 1 and 2, respectively.

CONCLUSIONS

Our data showed that GA at birth has little impact on bladder pattern so as to clinical outcome.

These data reinforce the need to follow these patients very closely irrespectively of earlier or later

age at birth.

12:54–13:06

Discussion